IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-65110-6.html
   My bibliography  Save this article

Serum Proteomics Reveals Diagnostic Biomarkers and Molecular Pathways in Cerebral Palsy

Author

Listed:
  • Yiran Xu

    (The Third Affiliated Hospital and Institute of Neuroscience of Zhengzhou University, Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center)

  • Chi Ma

    (Fudan University, Clinical Research Center for Cell-based Immunotherapy of Shanghai Pudong Hospital, Fudan University Pudong Medical Center, State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Human Phenome Institute)

  • Yanyan Sun

    (Zhengzhou University, Department of Human Anatomy, School of Basic Medicine)

  • Jiajun Zhu

    (Fudan University, Clinical Research Center for Cell-based Immunotherapy of Shanghai Pudong Hospital, Fudan University Pudong Medical Center, State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Human Phenome Institute)

  • Shiman He

    (Fudan University, Clinical Research Center for Cell-based Immunotherapy of Shanghai Pudong Hospital, Fudan University Pudong Medical Center, State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Human Phenome Institute)

  • Hui Gao

    (The Third Affiliated Hospital and Institute of Neuroscience of Zhengzhou University, Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center)

  • Subei Tan

    (Fudan University, Clinical Research Center for Cell-based Immunotherapy of Shanghai Pudong Hospital, Fudan University Pudong Medical Center, State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Human Phenome Institute)

  • Lingling Zhang

    (The Third Affiliated Hospital and Institute of Neuroscience of Zhengzhou University, Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center)

  • Jinwen Feng

    (Fudan University, Clinical Research Center for Cell-based Immunotherapy of Shanghai Pudong Hospital, Fudan University Pudong Medical Center, State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Human Phenome Institute)

  • Yangong Wang

    (Children’s Hospital of Fudan University and Institutes of Biomedical Sciences of Fudan University)

  • Sha Tian

    (Fudan University, Clinical Research Center for Cell-based Immunotherapy of Shanghai Pudong Hospital, Fudan University Pudong Medical Center, State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Human Phenome Institute)

  • Qinghe Xing

    (Children’s Hospital of Fudan University and Institutes of Biomedical Sciences of Fudan University)

  • Jiamei Zhang

    (The Third Affiliated Hospital and Institute of Neuroscience of Zhengzhou University, Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center
    Third Affiliated Hospital of Zhengzhou University, Department of Children Rehabilitation)

  • Yanan Wu

    (The Third Affiliated Hospital and Institute of Neuroscience of Zhengzhou University, Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center)

  • Xiaoli Zhang

    (The Third Affiliated Hospital and Institute of Neuroscience of Zhengzhou University, Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center)

  • Lirong Zhang

    (Zhengzhou, Department of Pharmacology, School of Basic Medical Sciences, Academy of Medical Science, Zhengzhou University)

  • Dengna Zhu

    (The Third Affiliated Hospital and Institute of Neuroscience of Zhengzhou University, Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center
    Third Affiliated Hospital of Zhengzhou University, Department of Children Rehabilitation)

  • Michael Kruer

    (Phoenix Children’s Hospital, Pediatric Movement Disorders Program, Barrow Neurological Institute
    University of Arizona College of Medicine Phoenix, Departments of Child Health, Neurology, Genetics and Cellular & Molecular Medicine)

  • Xiaoyang Wang

    (The Third Affiliated Hospital and Institute of Neuroscience of Zhengzhou University, Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center
    University of Gothenburg, Centre for Perinatal Medicine and Health, Institute of Clinical Sciences, Sahlgrenska Academy)

  • Jozef Gecz

    (The University of Adelaide, Robinson Research Institute and Adelaide Medical School)

  • Changlian Zhu

    (The Third Affiliated Hospital and Institute of Neuroscience of Zhengzhou University, Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center
    Karolinska Institutet, Department of Women’s and Children’s Health
    University of Gothenburg, Center for Brain Repair and Rehabilitation, Institute of Neuroscience and Physiology)

  • Chen Ding

    (Fudan University, Clinical Research Center for Cell-based Immunotherapy of Shanghai Pudong Hospital, Fudan University Pudong Medical Center, State Key Laboratory of Genetics and Development of Complex Phenotypes, School of Life Sciences, Human Phenome Institute)

Abstract

Cerebral palsy (CP), a prevalent non-progressive neurological disorder in children, lacks reliable biomarkers for early diagnosis, and its molecular mechanisms remain poorly understood. In this study, we conducted serum proteomic profiling of 346 CP patients and 190 healthy controls and developed a 10-protein multi-marker panel for application in diagnosis of CP. The panel was further validated in an independent CP cohort using an orthogonal method, enzyme-linked immunosorbent assay (ELISA). By integrating serum proteomic data with whole-exome sequencing (WES) results, we found that CP patients carrying pathogenic variants exhibited downregulation of synaptic and calcium signaling pathways at the protein level. We also explored the impact of clinical risk factors on the proteome, identifying disruptions in lipid metabolism associated with low birth weight and low gestational age. Additionally, we found a positive correlation between Immunoglobulin Heavy Variable (IGHV) families and higher Gross Motor Function Classification System (GMFCS) levels. Overall, our study provides a valuable tool for early CP diagnosis that complements standard clinical and genomic assessments, and suggests potential molecular mechanisms associated with CP pathogenesis, highlighting the interplay among genetic, environmental, and protein network factors.

Suggested Citation

  • Yiran Xu & Chi Ma & Yanyan Sun & Jiajun Zhu & Shiman He & Hui Gao & Subei Tan & Lingling Zhang & Jinwen Feng & Yangong Wang & Sha Tian & Qinghe Xing & Jiamei Zhang & Yanan Wu & Xiaoli Zhang & Lirong Z, 2025. "Serum Proteomics Reveals Diagnostic Biomarkers and Molecular Pathways in Cerebral Palsy," Nature Communications, Nature, vol. 16(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-65110-6
    DOI: 10.1038/s41467-025-65110-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-65110-6
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-65110-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-65110-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.